Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;97:488-495
Published online before print August 4, 2005, doi: 10.1161/01.RES.0000180663.42594.aa
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
97/5/488    most recent
01.RES.0000180663.42594.aav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lipskaia, L.
Right arrow Articles by Lompré, A.-M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lipskaia, L.
Right arrow Articles by Lompré, A.-M.
Related Collections
Right arrow Calcium cycling/excitation-contraction coupling
Right arrow Cell signalling/signal transduction
Right arrow Smooth muscle proliferation and differentiation
Right arrow Gene therapy
(Circulation Research. 2005;97:488.)
© 2005 American Heart Association, Inc.


Integrative Physiology

Sarco/Endoplasmic Reticulum Ca2+-ATPase Gene Transfer Reduces Vascular Smooth Muscle Cell Proliferation and Neointima Formation in the Rat

Larissa Lipskaia, Federica del Monte, Thierry Capiod, Sabrina Yacoubi, Lahouaria Hadri, Michel Hours, Roger J. Hajjar, Anne-Marie Lompré

From the INSERM U621/IFR-14 (L.L., S.Y., L.H., A.-M.L.), UPMC-CHU Pitié-Salpêtrière, Paris, France; the Cardiovascular Research Center (F.d.M., R.J.H.), Massachusetts General Hospital and Harvard Medical School, Charlestown, Mass; INSERM EMI 0228/IFR-118, USTL (T.C.), Villeneuve d’Ascq, France; and the Service de Cytometrie IBAIC (M.H.), IFR-FR46, Université Paris-Sud, Faculté des Sciences, Orsay, France.

Correspondence to Anne-Marie Lompré, INSERM U621, Faculté de Médecine Pitié-Salpétrière, 91 bd de l’Hôpital, 75634 Paris Cedex 13, France. E-mail lompre{at}chups.jussieu.fr

Proliferation of vascular smooth muscle cells (VSMC) is a primary cause of vascular disorders and is associated with major alterations in Ca2+ handling supported by loss of the sarco/endoplasmic reticulum calcium ATPase, SERCA2a. To determine the importance of SERCA2a in neointima formation, we have prevented loss of its expression by adenoviral gene transfer in a model of balloon injury of the rat carotid artery. Two weeks after injury, the intima/media ratio was significantly lower in SERCA2a-infected than in injured noninfected or injured ß-galactosidase–infected carotids (0.29±0.04 versus 0.89±0.19 and 0.72±0.14, respectively; P<0.05), and was comparable to that observed in control carotids (0.21±0.03). The pathways leading to proliferation were analyzed in serum-stimulated VSMC. Forced expression of SERCA2a arrested cell cycle at the G1 phase and prevented apoptosis. SERCA2a inhibits proliferation through inactivation of calcineurin (PP2B) and its target transcription factor NFAT (nuclear factor of activated T-cells) resulting in lowering of cyclin D1 and pRb levels. By using NFAT-competing peptide VIVIT, we showed that NFAT activity is strongly required to promote VSMC proliferation. In conclusion, we provide the first evidence that increasing SERCA2a activity inhibits VSMC proliferation and balloon injury–induced neointima formation.


Key Words: vascular smooth muscle cell proliferation • gene transfer • SERCA2a • calcium signaling • nuclear factor of activated T-cells




This article has been cited by other articles:


Home page
Am. J. Physiol. Cell Physiol.Home page
R. Berra-Romani, A. Mazzocco-Spezzia, M. V. Pulina, and V. A. Golovina
Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture
Am J Physiol Cell Physiol, September 1, 2008; 295(3): C779 - C790.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. J. House and H. A. Singer
CaMKII-{delta} Isoform Regulation of Neointima Formation After Vascular Injury
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 441 - 447.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Lipskaia, C. Pinet, Y. Fromes, S. Hatem, I. Cantaloube, A. Coulombe, and A.-M. Lompre
Mutation of {delta}-Sarcoglycan Is Associated with Ca2+-Dependent Vascular Remodeling in the Syrian Hamster
Am. J. Pathol., July 1, 2007; 171(1): 162 - 171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. J. House, R. G. Ginnan, S. E. Armstrong, and H. A. Singer
Calcium/calmodulin-dependent protein kinase II-{delta} isoform regulation of vascular smooth muscle cell proliferation
Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2276 - C2287.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Ying, X. Tong, D. R. Pimentel, R. M. Weisbrod, M. P. Trucillo, T. Adachi, and R. A. Cohen
Cysteine-674 of the Sarco/Endoplasmic Reticulum Calcium ATPase Is Required for the Inhibition of Cell Migration by Nitric Oxide
Arterioscler Thromb Vasc Biol, April 1, 2007; 27(4): 783 - 790.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
L. M. Nilsson, Z.-W. Sun, J. Nilsson, I. Nordstrom, Y.-W. Chen, J. D. Molkentin, D. Wide-Swensson, P. Hellstrand, M.-L. Lydrup, and M. F. Gomez
Novel blocker of NFAT activation inhibits IL-6 production in human myometrial arteries and reduces vascular smooth muscle cell proliferation
Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1167 - C1178.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. V. Koledova and R. A. Khalil
Ca2+, Calmodulin, and Cyclins in Vascular Smooth Muscle Cell Cycle
Circ. Res., May 26, 2006; 98(10): 1240 - 1243.
[Full Text] [PDF]